BIOCHEMICAL PARAMETERS IN THE DRUG TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE
- Authors: Mingalimova I.M1, Baleeva L.V1, Galeeva Z.M1, Galyavich A.S1
-
Affiliations:
- Kazan State Medical University
- Issue: Vol 31, No 3 (2020)
- Pages: 43-46
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114191
- DOI: https://doi.org/10.29296/25877305-2020-03-09
- ID: 114191
Cite item
Open Access
Access granted
Abstract
The mainstay of drug treatment in patients with chronic heart failure (CHF) is angiotensin-converting enzyme inhibitors, β-blockers, and mineral corticoid receptor antagonists, and, in edematous syndrome, diuretics. There is a drug treatment-induced change in number of biochemical blood parameters, such as plasma electrolytes, hormones, and catecholamines. The time course of biochemical blood changes induced by drug treatment in patients with CHF is important for the efficiency of the treatment and the control of its safety. The aim of the study was to investigate the impact of traditional inpatient drug treatment on a number of biochemical parameters in patients with obvious CHF.
Full Text
About the authors
I. M Mingalimova
Kazan State Medical University
Email: ilvera.maratovna@list.ru
L. V Baleeva
Kazan State Medical UniversityCandidate of Medical Sciences
Z. M Galeeva
Kazan State Medical UniversityCandidate of Medical Sciences
A. S Galyavich
Kazan State Medical UniversityMD
References
- Мареев В.Ю., Фомин И.В., Агеев Ф.Т. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН) // Сердечная недостаточность. - 2017; 18 (1): 3-40 doi: 10.18087/rhfj.2017.1.2346
- Triposkiadis F., Karayannis G., Giamouzis G. et al. The Sympathetic Nervous System in Heart Failure. Physiology, Pathophysiology, and Clinical Implications // J. Am. Coll. Cardiol. - 2009; 54: 1747-62. DOI: 10,1016/j.jacc.2009.05.015
- Lymperopoulos A., Rengo G., Koch W. Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy // Circulation Research. - 2013; 113: 739-53. DOI: 10,1161 / CIRCRESAHA.113.300308
- Grodin J., Verbrugge F., Ellis S. et al. Importance of Abnormal Chloride Homeostasis in Stable Chronic Heart Failure // Circ. Heart Fail. - 2016; 9: e002453. doi: 10.1161/CIRCHEARTFAILURE.115.002453
- Januzzi J., Rehman S., Mohammed A. et al. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction // J. Am. Coll. Cardiol. - 2011; 58: 1881-9. DOI: 10,1016 / j.jacc.2011.03.072
- Fonarow G., Peacock W., Phillips C. et al. Admission B-type natriuretic peptide levels and inhospital mortality in acute decompensated heart failure // J. Am. Coll. Cardiol. - 2007; 49: 1943-50. DOI: 10,1016/j.jacc.2007.02.037
- Cleland J., McMurray J., Kjekshus J. et al. Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) // J. Am. Coll. Cardiol. - 2009; 54: 1850-9. DOI: 10,1016 / j.jacc.2009.06.041
- Sachdeva A., Horwich T., Fonarow G. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure // Am. J. Cardiol. - 2010; 106: 830-5. DOI: 10.1016/j. amjcard.2010.04.045
- Troughton R., Felker G., Januzzi J. Natriuretic peptide-guided heart failure management // Eur. Heart J. - 2014; 35: 16-24. https://doi.org/10.1093/eurheartj/ eht463
- Latini R., Masson S., Anand I. et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure // Circulation. - 2007; 116: 1242-9. doi: 10.1161/CIRCULATIONAHA.106.655076
- Huelsmann M., Neuhold S., Resl M. et al. PONTIAC (NT-proBNP Selected PreventiOn of cardiac events in a population of dIabetic patients without A history of Cardiac disease): a prospective randomized controlled trial // J. Am. Coll. Cardiol. - 2013; 62: 1365-72. DOI: 10,1016 / j.jacc.2013.05.069
- Ledwidge M., Gallagher J., Conlon C. et al. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial // JAMA. - 2013; 310: 66-74. DOI: 10,1001 / jama.2013.7588
Supplementary files
